XM does not provide services to residents of the United States of America.
B
B

Brenntag

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Admiral, Capgemini, Zurich Insurance Group

EUROPE RESEARCH ROUNDUP- Admiral, Capgemini, Zurich Insurance Group Aug 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Capgemini and Zurich Insurance Group, on Thursday. HIGHLIGHTS * Admiral ADML.L : Jefferies raises to hold from underperform * Capgemini CAPP.PA : Jefferies cuts target price to EUR 185 from EUR 195 * Glenveagh Properties Plc GLV.I : Jefferies raises to buy from hold * Orsted ORSTED.CO : Deutsche Bank c
A
A
A
B
B
C
D
D
E
E
H
H
O
P
R
S
S
S
S
T
T
T
V
I
U
Z

Brenntag Acquires Specialty Chemicals Distributors PIC And PharmaSpecial

BRIEF-Brenntag Acquires Specialty Chemicals Distributors PIC And PharmaSpecial Aug 19 (Reuters) - BRENNTAG SE BNRGn.DE : BRENNTAG ACQUIRES SPECIALTY CHEMICALS DISTRIBUTORS PIC AND PHARMASPECIAL, EXPANDING PHARMA AND PERSONAL CARE MARKET PRESENCE IN BRAZIL CLOSING OF THE TRANSACTION IS SUBJECT TO CUSTOMARY CONDITIONS, INCLUDING REGULATORY APPROVALS
B

Brenntag CEO Says No Location Closures Currently Planned In Germany -Press Call

BRIEF-Brenntag CEO Says No Location Closures Currently Planned In Germany -Press Call Aug 13 (Reuters) - BRENNTAG SE BNRGn.DE : BRENNTAG CFO: WE WILL TAKE A CLOSE LOOK AT WHERE WE CAN CUT EXPENSES -PRESS CALL BRENNTAG CEO: WE WILL REVIEW LOCATIONS AND REDUCE STAFF IF CLOSED -PRESS CALL BRENNTAG CEO: NO LOCATION CLOSURES CURRENTLY PLANNED IN GERMANY
B

Healthy start ahead for European stocks

LIVE MARKETS-Healthy start ahead for European stocks Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com HEALTHY START AHEAD FOR EUROPEAN STOCKS European stocks are heading for a buoyant start to Tuesday, with EuroSTOXX50 STXEc1 futures up 0.36% and DAX futures FDXc1 ticking 0.31% higher.
B
T
E
F
U
G

Brenntag cuts outlook as chemical prices remain under pressure

UPDATE 2-Brenntag cuts outlook as chemical prices remain under pressure Adds shares in paragraph 4, detail on Q2 EBITA in paragraph 8, context in paragraph 9, cost cuts in paragraphs 10-11 By Tristan Veyet and Ozan Ergenay Aug 13 (Reuters) - German chemicals distributor Brenntag BNRGn.DE cut its outlook for 2024 late on Monday and said it expected markets to remain highly competitive, with sustained pressure on the selling prices of industrial chemicals.
B
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.